Epstein-Barr (EB) virus-immortalized B lymphocytes coexpress the EB viral latent gene products (EB viral nuclear antigens 1 to 6, the latent membrane protein and the terminal protein gene products) and the cellular activation antigen CD23. Immortalized B cells can be separated from those which are infected but not immortalized on the basis of CD23 expression as early as 2 days after in vitro infection. In the present report we have confirmed these data, but show that if left in culture for 7 days after infection before separation the CD23-negative cells show a donor-related ability to become CD23-positive and immortalize. CD23-negative cells separated 2 days after infection can be induced to immortalize by the addition of low Mr B cell growth factor but not by the addition of recombinant interleukin 1, 4 or soluble CD23. At 2 to 3 days after infection the EB viral nuclear antigens 1, 2 and the high Mr species 3, 4 and 6, as well as the latent membrane protein can be detected in the CD23-positive fraction. In contrast at this time only nuclear antigens 1 and 2 could be detected in the CD23-negative fraction. This difference in gene expression may account for the inability of the CD23-negative fraction to immortalize. In the light of these observations the mechanism of viral persistence in vivo is discussed.
Introduction
Epstein-Barr (EB) virus is a B lymphotropic human herpesvirus which is the causative agent of infectious mononucleosis (Henle et al., 1968) , a benign B lymphoproliferative disease, and is also associated with malignancies of the B cell type: Burkitt's lymphoma (Rowe & Gregory, 1989) and lymphoma in the immunocompromised (Cleary et al., 1986) . In vitro the virus infects B lymphocytes via the CD21 (CR2) molecule (Nemerow et al., 1985) , the receptor for the C3d component of complement, which is expressed on all mature B cells. Infection of these cells induces a lymphoblastoid cell phenotype and immortalization, giving rise to lymphoblastoid cell lines (LCL) which grow continuously in culture. In these cells the viral genome assumes a circular form and amplifies to give multiple nuclear episomes (Lindahl et al., 1976) . The majority of cells in an LCL express only the latent EB viral gene products which are compatible with continued cell proliferation. These include the EB viral nuclear antigen complex (EBNA) 1 to 6 (Dillner & Kallin, 1988; Allday et al., 1988) , the latent membrane protein (LMP) and the products of the terminal protein gene (Laux et al., 1988) . The functions of these proteins are for the most part unknown, but EBNA 1 is essential for maintenance of the viral episome (Yates et al., 1985) . EBNA 2 and LMP are suggested to have a role in the immortalization process since EBNA 2 deletion mutants of EB virus are non-immortalizing (Dambaugh et al., 1984) and LMP expression induces a tumorigenic phenotype in Rat-1 cells (Wang et al., 1985) . Immortalized B ceils also express cellular activation antigens consistent with their lymphoblastoid stage of differentiation. These include CD23 , which is upregulated by the EBNA 2 gene product (Wang et al., 1987) and is cleaved and shed from the cell surface acting as an autocrine growth factor for LCL (Swendeman & Thorley-Lawson, 1987) . A heterogeneity in the response of B cells to EB virus infection has been noted based on their expression of CD23. Thus, 2 to 3 days after infection, separation into CD23-positive and -negative fractions identifies the immortalizing cells exclusively within the CD23-positive fraction . The CD23-negative fraction contains cells expressing EBNA which do not immortalize, as well as EBNA-negative, terminally differentiated, immunoglo-T. Azim, M. J. Allday and D. H. Crawford bulin (Ig)-secreting plasma cells (Azim & Crawford, 1988) .
In the present report we have studied the immortalizing potential of CD23-negative ceils separated at 2 and 7 days after infection, and have analysed viral gene expression in the various fractions.
Methods
Preparation of E rosette-negative cells. Peripheral blood mononuclear cells were prepared from adult whole blood by centrifugation over Ficoll-Hypaque (Pharmacia). T lymphocytes were removed by rosetting with 2-aminoethylisothiouronium bromide (AET)-treated sheep red blood cells and a second centrifugation over Ficoll-Hypaque. The E rosette-negative cells were harvested and washed twice before use.
EB virus infection. EB virus stocks were prepared from the supernatant culture medium of the B95-8 cell line (Miller et al., 1972) by filtering through a 0-45 ~tm filter (Sartorius) and concentrating by highspeed centrifugation. Cell pellets were resuspended in virus preparations at around 107 cells/ml, and incubated at 37 °C for 1 h to allow attachment and penetration of the virus. The cells were then washed once before culturing.
Cellculture. CeIIs were cultured in RPMI 1640 containing 10% foetal calf serum, 100 units penicillin, 100 units streptomycin and 2 mMglutamine (Flow Laboratories). Initially, infected cells were cultured at 106/ml in 2 ml wells in Costar plates (Flow Laboratories), but after cell separation procedures the fractions were cultured in round-bottom 96-well plates (Flow Laboratories) in 200 ~tl of medium at a concentration of 104 per well. All cultures were incubated at 37 °C in a humidified atmosphere containing 5 % CO2 and were fed weekly by replacement of half the supernatant medium.
Cell separation procedures. Cells were incubated with the anti-CD23 monoclonal antibody MHM6 (kindly provided by Professor A. J. McMichael, Department of Immunology, University of Oxford, U.K.) for 30 min on ice and washed twice. Following this the ceils were either further incubated with an anti-mouse fluorescein-isothiocyanate (FITC)-conjugated antibody (Sigma) before separation into positive and negative fractions on a fluorescence-activated cell sorter (FACS) (Beckton Dickinson) or separated directly using anti-mouse Ig-coated magnetic beads (Dynal). FACS separation yielded both CD23-positive and CD23-negative populations for further analysis whereas magnetic bead separation was used only for negative cell selection since complete removal of the beads from the positive fraction could not be accomplished.
Immortalization assay. EB virus-infected cells were scored visually under an inverted microscope for the presence of continuously growing cell clumps over a 3 to 6 week period and continued cell growth on subculture.
Proliferation assay. Cells were incubated with tritiated thymidine (Amersham) (1 ~tCi per well) for the last 4 h of culture before harvesting on a cell harvester and assaying for thymidine incorporation on a flscintillation counter. The stimulation index was calculated relative to the uninfected control sample.
Growth factors. The following growth factors were used: recombinant interleukin 1 (rlL-1) (Biogen Research) (5 units/ml), low M r B cell growth factor (BCGF; Cytokine Technology) (1:10) recombinant interleukin 4 (rlL-4; a gift from Dr S. Gillis, Immunex, Seattle, Wash., U.S.A.) (103 units/ml), soluble CD23 (sCD23) purified from LCL culture supernatant (a gift from Dr R. Armitage and Ms L. K. Goff, Middlesex Hospital Medical School, London, U.K.) used at a concentration of 50% (v/v). A mock BCGF preparation (a gift from R. Callard, Institute of Child Health, London, U.K.) was made up containing: IL-2 (2units/ml), tumour necrosis factor c~ (TNF-~; 500 units/ml), interferon ~ (IFN-~; 500 units/ml) and used at a final concentration of 10% (v/v).
Immunofluorescence staining. Cells were stained in suspension by routine indirect immunofluorescence using the following monoclonal antibodies: MHM6 to detect CD23, UCHT1 to detect CD3-positive T lymphocytes and UCHM1 to detect CD14-positive monocytes (kindly provided by Dr P. C. L. Beverley, ICRF, London, U.K.). A second layer of anti-mouse Ig FITC-conjugated antibody (Sigma) was used and cell staining was analysed on the FACS. Staining for EBNA was by anti-complement immunofluorescence (ACIF) on cytospin preparations using positive and control negative human sera. On occasions this staining was doubled with staining for LMP using monoclonal antibodies CS1 to 4 and a rhodamine-conjugated anti-mouse Ig second layer (Sigma).
Immunoblotting. Protein extracts were prepared, separated by electrophoresis in 7.5% SDS-polyacrylamide gels, transferred to nitrocellulose and immunoblotted for EBNA species and LMP as previously described (Allday et al., 1988; Rowe et al., 1987) . A polyclonal human serum, RT (1 : 100), was used to probe EBNAs 1, 2, 3, 4 and 6 (Allday et al., 1988) and protein bands were visualized using an immunoperoxidase detection system. LMP was detected using the pool of monoclonal antibodies CS1 to 4 and protein bands were visualized using l ZSl.Protein A (Amersham)and autoradiography on Kodak XAR X-ray film.
Results
Following infection of E rosette-negative B cells with EB virus, 7 to 14% expressed CD23 at 2 days and 30 to 45% expressed CD23 at 7 days. The uninfected E-negative control ceils contained 0 to 5% of cells expressing CD23, 0 to 28% expressing UCHM1 and 0 to 9% expressing UCHT1.
CD23-positive and CD23-negative fractions were separated at 2 or 7 days post-infection either on a FACS or using magnetic beads. The fractions were cultured for a further 7 days before thymldme mcorporatton assays or for 3 to 6 weeks before scoring for immortalization. In all experiments all wells containing CD23-positive cells showed outgrowth of immortalized cells irrespective of the time of separation (Table 1) . Conversely no immortalized outgrowth occurred in the CD23-negative cells separated 2 days after infection (Table 1) . However when the CD23-positive and CD23-negative populations were separated at 7 days post-infection the results showed a donor-related variability in the incidence of immortalization of the CD23-negative fraction. Thus CD23-negative cells from four out of six donors showed immortalization whereas those from two out of six did not (Table 1 ). In two cases (donors 1 and 3) the same separation experiment was repeated on two or three separate occasions with the same result ( three cases (donors 3, 4 and 5) the separation was carried out at two time points in the same experiment (2 and 7 days), when the CD23-negative cells from two out of the three donors showed no immortalization at day 2 but did show immortalization at day 7 (Table 1) . CD23-negative cells were checked for contaminating CD23-positive cells which could have caused this outgrowth; less than 0.1% of CD23-positive cells were detected in the CD23-negative fraction immediately after separation. However, the CD23-negative cells from those donors whose cells showed immortalization rapidly became CD23-positive, with 7 to 10% positive at 2 days and 40 to 509/00 positive at 7 days after separation.
The effect of growth factors on proliferation and immortalization of the CD23-negative cells separated 2 days after infection was studied by adding BCGF, IL-1, IL-4 or sCD23 to the cultures immediately after separation. These factors were chosen because of their known ability to cause B cell activation and proliferation. The doses used were those recommended by the suppliers, and which were shown to enhance the proliferation of lymphoblastoid cell lines. In three out of five experiments BCGF caused the CD23-negative cells to immortalize, and in five out of seven experiments a significant increase of thymidine incorporation was noted ( Table 2 ). The BCGF preparation used has been shown to contain additional factors including IL-1, IL-2, IL-4, TNF-0q IgG, IgA, IgM and granulocyte-macrophage colony-stimulating factor (R. Callard, personal communication). Therefore a mock preparation was made containing IL-2, TNF-~ and IFN-o~ which are known to affect B cell growth, and added to the CD23-negative cultures at a 1:10 dilution to give final concentrations of the factors identical to those in the commercial BCGF. In two experiments no immortalization was induced by the mock BCGF although immortalization was induced in 100K of parallel cultures receiving BCGF (Table 3) . The position of LMP, Ig heavy chain (IgH, which was bound to the magnetic beads in the CD23-positive fraction and also binds the t2sI-Protein A probe) and M r standards are indicated. Lanes 1 and 2 were exposed to X-ray film for 7 days; lane 3 is an overnight exposure.
2 are expressed to about the same degree in both fractions ( Fig. 1 a, compare lanes 1 and 2) . On the other hand, expression of EBNAs 3, 4 and 6 did not appear equivalent in both populations. Despite there being protein from a greater number of cells in lane 2 (which corresponds to the CD23-negative population) EBNAs 3, 4 and 6 could not be detected, whereas in the CD23-
Discussion
CD23 is a cellular activation antigen which is rapidly induced by EB virus infection of B cells and which has been suggested to be essential for their immortalization, since B cells separated into CD23-positive and -negative fractions 2 days after EB virus infection show immortalization only in the CD23-positive fraction (ThorleyLawson & Mann, 1985) . We have confirmed these results but have detected a difference in the immortalizing potential between cells separated at 2 and 7 days postinfection. Thus, cells separated 7 days after infection from some donors immortalize whereas those separated at 2 days do not (Table 1 ). This finding is not likely to be due to contamination of the CD23-negative fraction with CD23-positive cells for several reasons: firstly, the level of contamination detected was less than 1 cell in 103; secondly, the same separation techniques were used throughout; thirdly, within the same experiments, cells from the same donors immortalized when separated at 7 days but not at 2 days. Repeated experiments on the same panel of donors show that immortalization of cells separated 7 days after infection is a donor-related event.
It is known that locally produced soluble factors are essential for the growth of immortalized cells in vitro. IL-1 is one of these factors (Blazar & Murphy,-1987) and another, which has been particularly well characterized, is the cleaved CD23 molecule which forms an autocrine loop (Swendeman & Thorley-Lawson, 1987) . It is possible therefore that CD23-negative cells separated at 2 days after infection are at a factor-dependent stage, needing to utilize factors produced by cocultured CD23-positive B cells or monocytes in order to immortalize. The role of these factors (perhaps in activating the B cells efficiently to a stage at which those EB viral genes necessary for immortalization can be transcribed) may be completed by 7 days, allowing the CD23-negative cells separated at this later stage to immortalize independently of exogenous factors.
In order to test this hypothesis we added exogenous IL-1, IL-4, sCD23 and BCGF to the CD23-negative cells separated 2 days after infection. BCGF induced CD23 expression and immortalization (Table 2) whereas the other factors did not, despite the fact that IL-4 is known to induce CD23 expression on B cells (Defrance et al., 1987) . Although the precise activity in the BCGF preparations used in this study required for immortalization has not been identified, we have eliminated the known contaminating agents which affect B cell growth by showing that our mock BCGF was devoid of immortalizing activity (Table 3 ). The precise identification of the factor inducing immortalization will have to await the use of cloned gene products.
It has been suggested that CD23 acts as a receptor for BCGF (Gordon et al., 1986) , with both molecules being cleaved from the cell surface and acting as an autocrine growth factor. The results of our experiments would suggest that this is unlikely, since the CD23-negative cells respond to the growth factor. Since the BCGF preparations used in our experiments and in those of Gordon et al. (1986) are identical it is possible that CD23 may be the receptor for one of the other ingredients of the BCGF preparation.
Up-regulation of CD23 has been reported after transfection of the isolated EBNA 2 or LMP genes into EB virus-negative Burkitt's lymphoma cells (Wang et al., 1987 (Wang et al., , 1988 . This suggests that these gene products are responsible, at least in part, for maintaining the high levels of expression of CD23 after the initial transient activation mediated by EB virus receptor binding. We were therefore interested to study the EB viral gene expression in the CD23-positive and CD23-negative fractions. Immunoblot analysis revealed that EBNA 1 and EBNA 2 were clearly expressed in both cell fractions (Fig. 1 a) . This result is interesting since the induction of CD23 has been specifically associated with EBNA 2 expression (Wang et al., 1987; Calender et al., 1987) . Our assumption is that a subpopulation of resting B cells exists which does not respond to EBNA 2 expression by becoming activated and expressing CD23. These cells may be at a point on the B cell differentiation pathway different to those directly susceptible to EB virusinduced proliferation and require the addition of BCGF to induce immortalization. Although EBNA 2 is necessary for immortalization (Dambaugh et al., 1984; Hammerschmidt & Sugden, 1989) these results clearly show it is not alone sufficient to cause immortalization of all B cells.
Although EBNAs 1 and 2 were found to be expressed in the cells from both fractions separated 2 to 3 days after infection, the high Mr EBNA species (EBNAs 3, 4, 6) were detected only in the CD23-positive fraction. The failure of the CD23-negative population to synthesize detectable levels of EBNAs 3, 4 and 6 (although the positive population does so at the same time point when similar numbers of cells are EBNA-positive by ACIF) suggests that the EBNA complex can be differentially expressed in B cell subsets; this has not been previously reported. An alternative explanation, which, although unlikely, cannot be ignored, is that CD23 induction may require coordinated expression of EBNAs 2, 3, 4 and 6 in resting cells and that the CD23-negative population results from infection with defective viruses. It is important also to note that although this experiment has been performed a number of times and the results were consistent, EBNAs 3, 4 and 6 are not always easily detected on immunoblots, particularly of proteins from small numbers of cells. Low level expression of these proteins in the CD23-negative populations cannot therefore be formally excluded.
CD23-negative cells do not express detectable levels of LMP (Fig. 1 b) . Their failure to be immortalized is therefore consistent with the hypothesis that LMP plays a key role in the induction of continuous proliferation of B cells (Wang et al., 1988) . The lack of expression does not, however, merely correlate with the absence of EBNA 2. (EBNA 2 is as abundant in the CD23-negative fraction as in the CD23-positive cells.) CD23-negative cells separated 2 days after infection do not contain circularized EB viral genomes whereas in the CD23-positive fraction a single circular genome per cell can be detected (Hurley & Thorley-Lawson, 1988) . It has been suggested that the circularization event requires the B cell to be in a specific state of activation (Hurley & Thorley-Lawson, 1988) and that LMP expression may also depend on the activation state of the cell and/or on the circularization process (Allday et al., 1989) . Thus it is possible that the EBNA-, LMP-and CD23-positive cells have become sufficiently activated to allow circularization and efficient LMP expression to occur but that the EBNA-positive, CD23-and LMP-negative cells need exogenous factors to reach this stage of activation. These would be provided in unseparated cultures by the CD23-positive B cells and/or cocultured monocytes, and in our experiments by the addition of BCGF, giving rise to a second wave of activation with CD23 expression, LMP expression, circularization of the viral genome and immortalization.
Thus, after EB virus infection of a B cell, a cascade of virus and cellular events must occur in a temporally ordered fashion before immortalization can take place. Although many of these events remain to be elucidated, our data, and those of Hurley & Thorley-Lawson (1988) , identify expression of the full EBNA complex and LMP, B cell activation with CD23 expression and genome circularization as essential for immortalization. We further suggest that LMP expression and genome circularization are dependent on prior activation of the B cell by some combination of virus binding CR2, EBNA expression and the activity of exogenous BCGF.
The significance of these observations to our understanding of the EB virus life cycle in vivo is worth considering. A reasonable assumption is that the ordered sequence of events following viral infection of resting virgin or memory B cells in vivo may mimic activation by antigen binding. This would lead to proliferation and clonal expansion of the activated lymphoblasts with subsequent terminal differentiation. One outcome could be tile expression of EB viral early antigens, structural proteins and a commitment to virus production with concomitant cell death, which has been demonstrated in maturing B cells in vitro (Crawford & Ando, 1986) . We have previously identified a cellular phenotype (that is, EBNA-positive, LMP-negative) which is found transiently after in vitro EB virus infection of resting B cells (Allday et al., 1989) , and here we have demonstrated an arrest point in the activation pathway which could lead to the accumulation in vivo of cells with a similar phenotype. Interestingly, tumour cells frozen at the mature resting B cell stage of differentiation (that is, chronic lymphatic leukaemia cells) have an identical phenotype after in vitro EB virus infection (Walls et al., 1990) . From an immunological point of view the EBNApositive, LMP-negative phenotype is potentially very interesting. Firstly, being incompletely activated into cycle and not committed to proliferation and terminal differentiation, these may still, in essence, be resting B cells and therefore long-lived. Secondly, because they do not express LMP, they would not be expected to express the high levels of cell surface adhesion molecules (CAM) such as leukocyte function antigens 1 and 3 and ICAM1 which are found on fully activated lymphoblasts and are associated with LMP expression (Wang et al., 1988) (in vitro studies suggest that EBNA-positive, LMP-negative cells are also LFAl-negative; unpublished observations). Adhesion molecules are knoWn to be important for physical interactions between B and T cells, in particular the killing of virus-infected B cells by cytotoxic T lymphocytes (CTL). Thus, although EB viral nuclear proteins [including EBNA 2 which is known to contain epitope(s) recognized by CTL (Moss et al., 1988) ] are expressed in these 'arrested' cells, their failure to express adherence molecules would make them poor targets for CTL. Thus they would have a high probability of evading elimination while carrying EB virus in a latent form. Subsequent activation of these cells by exogenous factor(s) could then re-open the pathway for clonal expansion and virus production as outlined above. Previous models of EB virus persistence in B cells have assumed that expression of viral antigens in such cells would be restricted to EBNA 1 (recently reviewed by Klein, 1989) . Our data suggest that viral persistence (and reactivation) could occur in cells with a rather less restricted pattern of viral gene expression, perhaps analogous to the cells we have demonstrated in vitro.
